(Q36753439)

16 August 2017

title

Fractures in children with Pompe disease: a potential long-term complication (English)

1 reference

16 August 2017

3

1 reference

16 August 2017

Laura E Case

1

1 reference

16 August 2017

Rabi Hanna

2

1 reference

16 August 2017

Vidya Krishnamurthy

4

1 reference

16 August 2017

Stephanie DeArmey

5

1 reference

16 August 2017

Joanne Mackey

6

1 reference

16 August 2017

Anne Boney

7

1 reference

16 August 2017

Claire Morgan

8

1 reference

16 August 2017

Deyanira Corzo

9

1 reference

16 August 2017

Susan Bouchard

10

1 reference

16 August 2017

Thomas J Weber

11

1 reference

16 August 2017

Yuan-Tsong Chen

12

1 reference

16 August 2017

Priya S Kishnani

13

1 reference

16 August 2017

publication date

7 March 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

37

1 reference

16 August 2017

issue

5

1 reference

16 August 2017

page(s)

437-445

1 reference

https://scigraph.springernature.com/pub.10.1007/s00247-007-0428-y

16 August 2017

exact match

0 references

cites work

Osteoporosis in children who have disabilities

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00247-007-0428-Y

Current treatment of adult Duchenne muscular dystrophy

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00247-007-0428-Y

Pompe disease in infants and children

21 January 2018

1 reference

12 December 2020

Osteopenia and osteoporosis: previously unrecognized manifestations of Fabry disease

1 reference

12 December 2020

Bone mineral density in a paediatric spinal muscular atrophy population

1 reference

12 December 2020

A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease

1 reference

12 December 2020

Birth fractures in spinal muscular atrophy

1 reference

12 December 2020

Extremity fractures in children with neuromuscular disease

1 reference

12 December 2020

Enzyme therapy for pompe disease with recombinant human alpha-glucosidase from rabbit milk

1 reference

12 December 2020

Bone density and metabolism in children and adolescents with moderate to severe cerebral palsy

1 reference

12 December 2020

Bone health in Duchenne muscular dystrophy: a workshop report from the meeting in Cincinnati, Ohio, July 8, 2004

1 reference

12 December 2020

Fractures caused by falling from a wheelchair in patients with neuromuscular disease

1 reference

12 December 2020

Report of a Muscular Dystrophy Campaign funded workshop Birmingham, UK, January 16th 2004. Osteoporosis in Duchenne muscular dystrophy; its prevalence, treatment and prevention

1 reference

12 December 2020

Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease

1 reference

12 December 2020

Renal magnesium wasting, hypomagnesemic hypocalcemia, hypocalciuria and osteopenia in a patient with glycogenosis type II

1 reference

12 December 2020

[Pain, osteopenia and body composition of 22 patients with Duchenne muscular dystrophy: a descriptive study]

1 reference

12 December 2020

Pompe disease diagnosis and management guideline.

1 reference

12 December 2020

Bone mineral density and fractures in boys with Duchenne muscular dystrophy

1 reference

12 December 2020

The effect of a weight-bearing physical activity program on bone mineral content and estimated volumetric density in children with spastic cerebral palsy

1 reference

12 December 2020

Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk

1 reference

12 December 2020

Recombinant human alpha-glucosidase from rabbit milk in Pompe patients.

1 reference

12 December 2020

Vertebral fractures in boys with Duchenne muscular dystrophy

1 reference

12 December 2020

Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I/II clinical trial

1 reference

12 December 2020

Bone mineral density and bone metabolism in Duchenne muscular dystrophy

1 reference

12 December 2020

Fracture prevalence in Duchenne muscular dystrophy

1 reference

12 December 2020

Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial

1 reference

12 December 2020

Hyperkyphotic posture and risk of future osteoporotic fractures: the Rancho Bernardo study

1 reference

12 December 2020

Vertebral compression in Duchenne muscular dystrophy following deflazacort

1 reference

12 December 2020

Pathological fractures in patients with cerebral palsy

1 reference

12 December 2020

How to manage osteoporosis in children

1 reference

12 December 2020

Low magnitude mechanical loading is osteogenic in children with disabling conditions.

1 reference

12 December 2020

The effect of kyphosis on the mechanical strength of a long-segment posterior construct using a synthetic model

1 reference

12 December 2020

Fractures in myopathies

1 reference

12 December 2020

Alendronate in the treatment of low bone mass in steroid-treated boys with Duchennes muscular dystrophy

1 reference

12 December 2020

Osteoporosis after spinal cord injury

1 reference

12 December 2020

Official positions of the international society for clinical densitometry.

1 reference

12 December 2020

Musculoskeletal complications associated with lysosomal storage disorders: Gaucher disease and Hurler-Scheie syndrome (mucopolysaccharidosis type I).

1 reference

12 December 2020

Chinese hamster ovary cell-derived recombinant human acid alpha-glucosidase in infantile-onset Pompe disease

1 reference

12 December 2020

Effects of a dynamic versus a static prone stander on bone mineral density and behavior in four children with severe cerebral palsy

1 reference

12 December 2020

The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature

1 reference

12 December 2020

Bone mineral status in paraplegic patients who do or do not perform standing.

1 reference

12 December 2020

Fracture risk in patients with muscular dystrophy and spinal muscular atrophy

1 reference

12 December 2020

10.1007/S00247-007-0428-Y

Identifiers

DOI

1 reference

16 August 2017

1 reference